Detalhe da pesquisa
1.
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Ann Oncol
; 30(8): 1321-1328, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125062
2.
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study.
Ann Oncol
; 29(11): 2214-2222, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215676